[Generic Equivalent of Cipro]
Prescription Required
Quantity:90
Price:$49.99$1.33 per unit
Country: United States
Please Select... 90 from United Kingdom (UK) $49.99 100 from Canada (CA) $99.99
00983642503
The generic Ciprofloxacin Tablets 250 mg by Amneal is manufactured by Amneal Pharmaceuticals of India. It is available in the quantity of 90 tablets and 100 tablets.
Canada from United Kingdom (UK) $49.99 100 from Canada $99.99
Quantity100
Canada from United Kingdom (UK) $49.99 100 from United Kingdom (UK) $99.99
Manufacturer:
Aneal Pharmaceuticals of IndiaManufactured by Aneal Pharmaceuticals of India
Pack size:
1 tablets
Manufactured by:
100 tablets
1 pack
Salt Composition in both
Salt Composition
Ciprofloxacin 500mg(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Floxip 500mg Tablet 10s
3,686+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Request my help:Please call us at 1-800-430-3822 to submit additional request.
We offer both standard and productysellers' deliveries. We also offer express and post methods. All services are authorized by the manufacturer and are compliant with federal and international health regulations.
The top five delivery options for both GMP and GMCP certified Pplox are listed below.
USD 50.
Ciprofloxacin HCLac:Treatment of bacterial infections; Specificity andbidity of bacterial infections;
Ciprofloxacin HCLac should be taken orally as a single 50 mg dose orraag. For infections in the ear, the usual initial dose is 1-2 grams every 2 hours to 30-60 mg rise in levels, depending on the specific infection. For infections in the nose, the dose is given as a 50 mg dose or as2 grams inin in 7-10 days dose. The dose may be doubled in children and halved in young patients to provide providing effects. The dose of Ciprofloxacin HCLac should not be given more frequently than once per day. The dose should be given as 2 grams each day. For children over 5 years of age, the recommended initial dose is1 gram given as 2 grams twice daily at doses at least 5 days in total. For children 8 years or less, the dose should be adjusted in accordancewith the child’s weight. For elderly patients, the dose should be adjusted in accordancewith the elderly patient's condition and with the elderly's continued treatment. Based on the dosing information, the dose of Ciprofloxacin HCLac should be considered as single 50 mg dose orra in the treatment of the following infections in the ear (e.g., tonsillitis, pharyngitis, pharyngitis, otorreliglottitis).
Ciprofloxacin HCLac should be administered to pediatric patients for a range of bacterial infections (e.g., acute otitis media, sinusitis, otitis media in children). The dose of Ciprofloxacin HCLac should be administered to pediatric patients ages 7 years or less, in a dose-ranging fashion, in adults and children and adolescents above 5 years of age. The dose of Ciprofloxacin HCLac should be administered to pediatric patients ages 7 years or less, in a dose-ranging fashion, in adults and children. The dose of Ciprofloxacin HCLac should be administered to pediatric patients aged over 5 years, in a dose-ranging fashion, in adults and children, and adolescents above 5 years of age. Based on the available data, the dose of Ciprofloxacin HCLac should be taken as single 50 mg dose or as 2 grams each day. For children, the recommended initial dose is 2 grams inin in a dose of 1 grams each day. For children 8 years or less, the recommended initial dose is 2 grams inin a dose of 2 grams inin in in a dose of 2 grams inin in a dose of 2 grams inin a dose of 2 grams inin a dose of 2 grams.
We are an international company that specializes in the production, testing, and manufacturing of a wide range of pharmaceuticals, including some of the most popular brands in the world, like generic drugs. We are an international company with a long history of providing high quality, high value products and services at competitive prices to help customers get their business back in order. We are looking to help you take the next step in your business and get back to doing what you love. We are based in the United Kingdom, Germany, Spain, Italy, France, and Germany. We are a global company that specializes in the production, testing, and manufacturing of a wide range of pharmaceuticals. Our manufacturing facility is located in the US. We have a robust supply chain of over 10,000 employees and provide the latest pharmaceuticals to over 25 countries. We have a dedicated team that includes our highly trained and experienced team, who are dedicated to providing the most cost effective products to our customers. We are looking to start our manufacturing business in India.
Our range of pharmaceuticals is a growing number of companies in the market. With the advancements in technology and manufacturing, we have successfully manufactured the following products:
At the present time, we are working with other pharmaceutical companies to offer our products to our customers. We are committed to providing high quality, high value and high-quality products to our customers in a safe and affordable way to ensure that their business goes smoothly and to improve their health.
Ciprofloxacin and its generic equivalents may soon be available in the UK. This is a relatively new product, introduced in the US in December, and is expected to be available to patients in the form of tablets (Ciprofloxacin Tablets, Pfizer, 2000). Ciprofloxacin is a fluoroquinolone antibiotic thataquinized with quinolone resistance, and it has been used to treat a variety of bacterial infections. Ciprofloxacin may soon be available over the counter in the UK from pharmacies such as (Ciplox,) as a generic drug, and as a brand drug from Roche, as well as from the manufacturer's website.
Ciprofloxacin is a fluoroquinolone, also called levofloxacin, which is a member of the antibiotic fluoroquinolone antibiotic class, and it has been used to treat bacterial infections for more than a century. Ciprofloxacin is fluoroquinolone-resistant and is also used to treat infections caused by certain bacteria. Ciprofloxacin is also used in the treatment of lung infections, urinary tract infections, respiratory tract infections, and an infection in the vagina caused by an infection in the liver.
A patent for Ciprofloxacin expired in June 1999, and the US Food and Drug Administration granted Ciprofloxacin Patent No. 2,071,814 on 29 March 2000. However, Ciprofloxacin has not yet been approved for the UK market. The patent for Ciprofloxacin expired in June 1999, and the US Food and Drug Administration granted Ciprofloxacin Patent No.
Patents for generic drugs have expired in the UK and the US. Generic drugs are produced and sold by other companies that are now permitted to produce Ciprofloxacin Tablets, and these Tablets are called fluoroquinolones.
Fluoroquinolones have anti-bacterial properties, and are also used to treat bacterial infections. The active ingredient in Ciprofloxacin is fluoroquinolone-1,4,5-tricalescel 4,6-dimethylc-8-en-3-yl-l-quinolone, and the patent for Ciprofloxacin expired in June 1999.
The patent for generic drug Ciprofloxacin expired in June 1999, and the patent for the most popular member of the antibiotic fluoroquinolones has now expired.
Levofloxacin (Factive, Pfizer, 2000) is a fluoroquinolone patent-protected version of Ciprofloxacin. Levofloxacin (Factive) was the last fluoroquinolone patent to expire until patent protection expired for other members of the class. In June 2000, Pfizer (Pfizer), the developer of generic drug Ciplox, announced that it had granted a exclusive license to GlaxoSmithKline (GSK) to produce a generic version of Levofloxacin Tablets. This patent extension will allow Glaxo to produce the Levofloxacin Tablets from the US market.
References:
1. Ciprofloxacin Patent No 2,071,814, 29 March 2000. US. Patent Document 0049-23, Ser. No. 98/23,821. EMA. 2001. http://www.ncbi.nlm.nih.gov/books/NBK934983/.
2. Bayer A. (2003). Drug Guide.orr.com. Accessed on 29/04/03.
http://www.drugguide.com/drugguide-ciprofloxacin-drug.htmlhttp://www.drugguide.com/ciprofloxacin-equivalent-norcofloxacin-equivalent.htmlhttp://www.med.medscape.com/article.asp? ID=2030-09-03/ciprofloxacin-norcofloxacin-norcofloxacin-drug.htmhttp://www.drugtrials.org.uk/drug_trials/ciprofloxacin-norcofloxacin.htmlhttp://www.drugtrials.com/ciprofloxacin-tablets.htmlhttp://www.drugtrials.